Title:
NUCLEOCAPSID-DERIVED ANTIGEN PEPTIDE, NUCLEIC ACID, VECTOR, PHARMACEUTICAL COMPOSITION, HLA/ANTIGEN PEPTIDE COMPLEX, AND METHOD FOR DETECTING T CELL
Document Type and Number:
WIPO Patent Application WO/2024/085143
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a novel peptide that could be used to induce an immune response to SARS-CoV-2. A nucleocapsid-derived antigen peptide according to the present disclosure includes the following polypeptide (P1), (P2) or (P3): (P1) a polypeptide comprising an amino acid sequence represented by SEQ ID NO: 1 (KAYNVTQAF); (P2) a polypeptide comprising an amino acid sequence obtained by deleting, inserting, substituting, or adding 1-6 amino acids in the amino acid sequence represented by SEQ ID NO: 1; and (P3) a polypeptide comprising an amino acid sequence having at least 80% identity to the amino acid sequence represented by SEQ ID NO: 1.
Inventors:
MOTOZONO CHIHIRO (JP)
UENO TAKAMASA (JP)
GOTO YOSHIHIKO (JP)
KISHI HIROYUKI (JP)
HAMANA HIROSHI (JP)
UENO TAKAMASA (JP)
GOTO YOSHIHIKO (JP)
KISHI HIROYUKI (JP)
HAMANA HIROSHI (JP)
Application Number:
PCT/JP2023/037529
Publication Date:
April 25, 2024
Filing Date:
October 17, 2023
Export Citation:
Assignee:
UNIV KUMAMOTO NAT UNIV CORP (JP)
NATIONAL UNIV CORPORATION UNIV OF TOYAMA (JP)
NATIONAL UNIV CORPORATION UNIV OF TOYAMA (JP)
International Classes:
C12N15/50; A61K38/16; A61K39/00; A61K39/395; A61P31/14; A61P37/04; A61P43/00; C07K14/165; C07K14/74; C07K19/00; C12N15/63; C12Q1/04
Attorney, Agent or Firm:
IP Law Firm Lexceed Tech (JP)
Download PDF:
Previous Patent: POLYVINYL ALCOHOL FILM AND STRETCHED FILM
Next Patent: ALLERGEN INHIBITOR AND ALLERGEN INHIBITION PRODUCT
Next Patent: ALLERGEN INHIBITOR AND ALLERGEN INHIBITION PRODUCT